Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01396096 · ClinicalTrials.gov registry record
Comparison of Obesity Alleles Among Diverse Demographic Patients
A clinical trial, sponsored by NYU Langone Health.
- Completed
- Registry status
- 2,500
- Enrollment target
NCT01396096: Completed study, sponsored by NYU Langone Health.
NCT01396096 is a clinical trial that has completed, run by NYU Langone Health. The registered enrollment target is 2,500 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01396096 has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- 2,500 participants
- Enrollment target
Study Summary
This proposal is designed to (1) establish the feasibility of a research strategy for discovering ethnic differences in the frequency of genotypes in patients after bariatric surgery and (2) perform a preliminary evaluation of this research strategy. Our goal is to identify genetic factors that may influence the success of various surgical weight loss interventions and determine whether these factors are associated with specific patient populations.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,500 participants |
| Start Date | 2011-06 |
| Est. Completion | 2025-10-24 |
What the finished NCT01396096 record still lists
NCT01396096 is an observational study that tracks outcomes without assigning an intervention. Its 2,500 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT01396096 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01396096 about?
NCT01396096 is a clinical study titled "Comparison of Obesity Alleles Among Diverse Demographic Patients". This proposal is designed to (1) establish the feasibility of a research strategy for discovering ethnic differences in the frequency of genotypes in patients after bariatric surgery and (2) perform a preliminary evaluation of this research strategy. Our goal is to identify genetic factors that may ...
What is the current status of trial NCT01396096?
This trial is currently completed. The enrollment target is 2,500 participants. The study started on 2011-06. Estimated completion is 2025-10-24.
Who is sponsoring clinical trial NCT01396096?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001160 · 2,500 participants
Studies on Tumors of the Thyroid
- NCT01904188 · 2,500 participants
Clinical Microbial Species & Antibiotic Resistance ID in ED Patients Presenting With Infection - is Rapid ID Possible & Accurate?
- NCT02257229 · 2,500 participants
Prospective Evaluation of Treatment for Clubfoot
- NCT02530658 · 2,500 participants
Next Generation Sequencing of Normal Tissues Prospectively in Pediatric Oncology Patients
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia